Patients with a history of thyroid cancer, pregnancy, or severe digestive disease may not qualify
Low doses of GLP-1 receptor agonists are really powerful for reducing A1C, or the average glucose in the blood, says John Buse, a professor of medicine at UNC School of Medicine and co-director of the North Carolina Translational and Clinical Sciences Institute, in a media release
The side effects of BPC-157 are not fully documented due to its investigational status, but current research and anecdotal reports suggest it is generally well-tolerated
The study, known as FOCUS, is enrolling 1,500 patients, who will be randomized to receive either placebo or semaglutide in addition to their diabetes medications
Zepbound is injected subcutaneously (under the skin) once a week in the stomach, thigh, or back of the upper arm
We serve patients from Pasadena TX, South Houston TX, Brookwood TX, Clear Lake TX, Baytown TX, and surrounding areas